邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

欧洲临床微生物和感染病大会2018精要概述

杨启文,  周梦兰,  徐英春

downloadPDF
文章导航 > 协和医学杂志  > 2018 >  9(5): 474-478
杨启文, 周梦兰, 徐英春. 欧洲临床微生物和感染病大会2018精要概述[J]. 协和医学杂志, 2018, 9(5): 474-478. doi: 10.3969/j.issn.1674-9081.2018.05.019
引用本文: 杨启文, 周梦兰, 徐英春. 欧洲临床微生物和感染病大会2018精要概述[J]. 协和医学杂志, 2018, 9(5): 474-478. doi: 10.3969/j.issn.1674-9081.2018.05.019
shu
Qi-wen YANG, Meng-lan ZHOU, Ying-chun XU. The Concise Overview of the 28th European Conference on Clinical Microbiology and Infectious Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 474-478. doi: 10.3969/j.issn.1674-9081.2018.05.019
Citation: Qi-wen YANG, Meng-lan ZHOU, Ying-chun XU. The Concise Overview of the 28th European Conference on Clinical Microbiology and Infectious Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 474-478. doi: 10.3969/j.issn.1674-9081.2018.05.019
shu

欧洲临床微生物和感染病大会2018精要概述

doi: 10.3969/j.issn.1674-9081.2018.05.019
  • 1.

    中国医学科学院 北京协和医学院 北京协和医院检验科， 北京 100730

  • 2.

    中国医学科学院 北京协和医学院研究生院， 北京 100005

基金项目: 

北京市东城区优秀人才培养资助项目 2017

科技部国家重点研发计划 2018YFC1200100

中国医学科学院医学与健康创新工程 2016-I2M-1-014，2016-I2M-3-014

北京协和医学院研究生创新基金 2017-1002-1-21

详细信息
    通讯作者:

    徐英春 电话：010-69159766，E-mail ：xycpumch@139.com

  • 中图分类号: R446.1

The Concise Overview of the 28th European Conference on Clinical Microbiology and Infectious Diseases

  • 1.

    Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

  • 2.

    Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China

More Information
    Corresponding author: XU Ying-chun   Tel:010-69159766，E-mail ：xycpumch@139.com

    摘要
  • 摘要: 2018年4月21至24日，第28届欧洲临床微生物和感染病大会在西班牙马德里隆重召开。本次大会聚焦多个临床微生物与感染性疾病相关热点话题，包括欧洲药敏试验委员会折点系统更新、血培养直接药敏试验的标准化、铜绿假单胞菌菌血症新型预后标志物HeIP、革兰阴性菌菌血症抗菌药物治疗7 d不逊于14 d、西尼罗河病毒在希腊南部再次出现、荷兰感染危险扫描系统助力感染控制、磷霉素新型耐药机制-uhpB和uhpC突变、耳念珠菌在英国重症监护病房暴发、mazEF毒素-抗毒素系统可作为新型抗菌药物的靶点等。此次会议也发出了多个中国声音，包括中国细菌耐药监测网首次在大会亮相以及华人抗菌药物敏感性试验委员会第二次工作会议暨全球华人临床微生物和感染学会中欧论坛成功举办。
    Abstract: The 28th European Conference on Clinical Microbiology and Infectious Diseases (ECCMID) opened with a great ceremony from 21st to 24th, April 2018 in Madrid, Spain. This meeting focused on several hot topics concerning clinical microbiology and infectious diseases，including the breakpoints update of the European Committee on Antimicrobial Susceptibility Testing (EUCAST), EUCAST rapid antimicrobial susceptibility testing by disk diffusion directly from blood culture bottles, HeIP as a new prognostic biomarker for patients with bloodstream infection of Pseudomonas aeruginosa, the comparable effect of 7-day versus 14-day antimicrobial therapy for gram-negative bacteremia, reemergence of West Nile Virus infection in humans in Southern Greece, the implementation of the infection-risk scan in a Dutch hospital resulting in standardization, transparency and substantial improvement, novel mechanisms of fosfomycin resistance in Escherichia coli, the outbreak of Candida auris infection in a UK intensive care unit, mazEF bacterial toxin-antitoxin systems as targets for novel antimicrobials, and so on. Besides, China also showed its stories in the conference, including the first introduction of China Antimicrobial Resistance Surveillance System, the successful hosting of the second work meeting of Chinese Committee on Antimicrobial Susceptibility Testing, and China-Europe Forum of Global Chinese Association of Clinical Microbiology and Infectious Diseases.
    • HTML全文
    • 参考文献(17)
  • [1] Mouton JW, Meletiadis J, Voss A, et al. Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision[J]. J Antimicrob Chemother, 2018, 73:2374-2379. doi:  10.1093/jac/dky232
    [2] Haldorsen B, Giske CG, Hansen DS, et al. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study[J]. J Antimicrob Chemother, 2018.doi:  10.1093/jac/dky339. [Epub ahead of print].
    [3] Turnidge J, Lina G, Giske C, et al. A plea from EUCAST for standardisation of disk susceptibility testing antimicrobial codes [J]. Clin Microbiol Infect, 2018.doi:  10.1016/j.cmi.2018.08.007. [Epub ahead of print].
    [4] Sahu C, Jain V, Mishra P, et al. Clinical and laboratory standards institute versus European committee for antimic-robial susceptibility testing guidelines for interpretation of carbapenem antimicrobial susceptibility results for Escherichia coli in urinary tract infection (UTI) [J].J Lab Physicians, 2018, 10:289-293. doi:  10.4103/JLP.JLP_176_17
    [5] Nichols WW, Stone GG, Newell P, et al. Ceftazidime-Avibactam Susceptibility Breakpoints Against Enterobacteriaceae and Pseudomonas aeruginosa [J].Antimicrob Agents Chemother, 2018.doi:  10.1128/AAC.02590-17. [Epub ahead of print].
    [6] Périllaud C, Pilmis B, Diep J, et al. Prospective evaluation of rapid antimicrobial susceptibility testing by disk diffusion on Mueller-Hinton rapid-SIR directly on blood cultures[J]. Diagn Microbiol Infect Dis, 2018. doi:  10.1016/j.diagmicrobio.2018.07.016. [Epub ahead of print].
    [7] Chotiprasitsakul D, Han JH, Cosgrove SE, et al. Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort[J].Clin Infect Dis, 2018, 66:172-177. doi:  10.1093/cid/cix767
    [8] Uno S, Hase R, Kobayashi M, et al.Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia[J]. Int J Infect Dis, 2017, 55:81-85. doi:  10.1016/j.ijid.2016.12.018
    [9] Ivády B, KeneseiÉ, Tóth-Heyn P, et al. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children[J].Infection, 2016, 44:309-321. doi:  10.1080/23744235.2018.1492150
    [10] Blot S. Setting the baseline to fight Gram-negative bactera-emia: the necessity of epidemiological insights[J]. Infect Dis (Lond), 2018,1-3.doi:  10.1080/23744235.2018.1492150. [Epub ahead of print].
    [11] Hawkes MA, Toledano M, Kaufmann TJ, et al. West Nile Neuroinvasive Disease Presenting as Elsberg Syndrome[J].Neurologist, 2018, 23:152-154. doi:  10.1097/NRL.0000000000000189
    [12] Haussig JM, Young JJ, Gossner CM, et al. Early start of the West Nile fever transmission season 2018 in Europe[J]. Euro Surveill, 2018. doi:  10.2807/1560-7917.ES.2018.23.32.1800428. [Epub ahead of print].
    [13] Willemsen I, Kluytmans J. The infection risk scan (IRIS): standardization and transparency in infection control and antimicrobial use[J]. Antimicrob Resist Infect Control, 2018, 7:38. doi:  10.1186/s13756-018-0319-z
    [14] Willemsen I, Nelson-Melching J, Hendriks Y, et al. Measuring the quality of infection control in Dutch nursing homes using a standardized method; the Infection prevention RIsk Scan (IRIS) [J]. Antimicrob Resist Infect Control, 2014, 3:26. doi:  10.1186/2047-2994-3-26
    [15] Johnson CJ, Davis JM, Huttenlocher A, et al. Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack[J]. MBio, 2018.doi:  10.1128/mBio.01403-18. [Epub ahead of print].
    [16] Forsberg K, Woodworth K, Walters M, et al. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen[J]. Med Mycol, 2018.doi:  10.1093/mmy/myy054. [Epub ahead of print].
    [17] Nikolic N, Bergmiller T, Vandervelde A, et al. Autoregul-ation of mazEF expression underlies growth heterogeneity in bacterial populations[J]. Nucleic Acids Res, 2018, 46:2918-2931. doi:  10.1093/nar/gky079
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  216
  • HTML全文浏览量:  27
  • PDF下载量:  218
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-06-21
  • 刊出日期:  2018-09-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！